TrialCurrent oncology (Toronto, Ont.)2025

Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial.

Chang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.